Association between the RAGE gene -374T/A, -429T/C polymorphisms and diabetic nephropathy: a meta-analysis

References

• Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–176
   PubMed Web of Science ®Google Scholar
• Chowdhury TA, Dyer PH, Kumar S, Barnett AH, Bain SC. Genetic determinants of diabetic nephropathy. Clin Sci (Lond). 1999;96:221–230
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Uhlig K, Koukoulis GN, Papathanasiou AA, Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: A meta-analysis. J Hum Genet. 2007;52:881–890
   PubMed Web of Science ®Google Scholar
• Badal SS, Danesh FR. New insights into molecular mechanisms of diabetic kidney disease. Am J Kidney Dis. 2014;63:S63–S83
   PubMed Web of Science ®Google Scholar
• Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 1992;267:14998–15004
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Vianna M, Gerlach M, et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem. 1992;267:14987–14997
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb. 1994;14:1521–1528
   PubMed Web of Science ®Google Scholar
• Chavakis T, Bierhaus A, Al-Fakhri N, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment. J Exp Med. 2003;198:1507–1515
   PubMed Web of Science ®Google Scholar
• Kalea AZ, Schmidt AM, Hudson BI. RAGE: A novel biological and genetic marker for vascular disease. Clin Sci (Lond). 2009;116:621–637
   PubMed Web of Science ®Google Scholar
• Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18:1–14
   PubMed Web of Science ®Google Scholar
• Sugaya K, Fukagawa T, Matsumoto K, et al. Three genes in the human MHC class III region near the junction with the class II: Gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics. 1994;23:408–419
   PubMed Web of Science ®Google Scholar
• Hudson BI, Stickland MH, Futers TS, Grant PJ. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes. 2001;50:1505–1511
   PubMed Web of Science ®Google Scholar
• Poirier O, Nicaud V, Vionnet N, et al. Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patients. Diabetes. 2001;50:1214–1218
   PubMed Web of Science ®Google Scholar
• Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M, Grant PJ, Groop PH. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes. 2003;52:891–894
   PubMed Web of Science ®Google Scholar
• Xu JX, Xu B, Yang MG, et al. -429T/C polymorphism of RAGE gene promoter is associated with type 2 diabetic nephropathy. China J Endocrinol Metab. 2004;20:534–535
   Google Scholar
• Xu JX, Yang MG, Liu JY, Chang YL, Zhang PW, Chen HX. Association between RAGE gene promoter -374T/A polymorphism and type 2 diabetes and nephropathy. Chin J Prev Contr Chron Non-Commun Dis. 2005;13:39–40
   Google Scholar
• Kankova K, Stejskalova A, Hertlova M, Znojil V. Haplotype analysis of the RAGE gene: Identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant. 2005;20:1093–1102
   PubMed Web of Science ®Google Scholar
• dos Santos KG, Canani LH, Gross JL, Tschiedel B, Pires Souto KE, Roisenberg I. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol Genet Metab. 2005;85:149–156
   PubMed Web of Science ®Google Scholar
• Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L, Agardh CD. Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One. 2008;3:e2546
   PubMed Web of Science ®Google Scholar
• Prasad P, Tiwari AK, Kumar KM, et al. Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Med Genet. 2010;11:52
   PubMed Web of Science ®Google Scholar
• Lindholm E, Bakhtadze E, Sjogren M, et al. The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia. 2006;49:2745–2755
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Ioannidis J. Heterogeneity testing in metanalysis of genome searches. Genet Epidemiol. 2005;28:123–137
   PubMed Web of Science ®Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–826
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
   PubMed Web of Science ®Google Scholar
• Weir B. Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland, MA: Sinauer Associates; 1996
   Google Scholar
• Feng P, Dan H, Nan J, et al. Association of four genetic polymorphisms of AGER and its circulating forms with coronary artery disease: A meta-analysis. PLoS One. 2013;8:e70834
   Google Scholar